Katrina Britton

Katrina Britton has a diverse work experience spanning over 25 years. Katrina currently holds the position of Associate Director of Manufacturing at Sage Therapeutics, a role they started in 2022. Prior to that, they worked at Capricor Therapeutics, Inc. as the Director of Quality from 2020 to 2022.

Before joining Capricor Therapeutics, Inc., Katrina worked at Kite Pharma, Inc. as a Senior Manager, Quality Operations, Clinical from 2016 to 2020. During their time at Kite Pharma, they led various quality initiatives, including the operationalization of a new clinical manufacturing facility and the development of a clinical patient re-dose process.

From 2012 to 2016, Katrina was associated with Shire (currently Takeda) as a Senior Manager, Small Volume Manufacturing and Pilot Operations. In this role, they led a cross-functional team in the successful launch of a new facility and product (BabyBIG), ensuring on-time delivery and a recordable injury rate of zero. Katrina also accomplished an FDA pre-approval inspection with no observations or recommendations.

Katrina's earlier experience includes roles at Baxter BioScience, Edwards Lifesciences, Tava Technologies, Simulation Sciences, Inc., and Keith International, Inc. At Baxter BioScience, they held multiple roles, including Manager of Quality Systems and Senior Manager of Engineering, Technical Services. At Edwards Lifesciences, they worked as a Supplier Quality Engineer and Manufacturing Engineer as part of the Operations Leadership Development Program.

Overall, Katrina Britton brings a wealth of experience in quality management, manufacturing, and operational leadership to their current role at Sage Therapeutics.

Katrina Britton has a Bachelor of Science degree in Chemical Engineering from UC Irvine. Additionally, they hold another Bachelor of Science degree in Environmental Science from the University of California, Riverside. However, the specific start and end years for their education at these institutions are not provided.